The lab instrumentation market
accounted for a reasonable share of the analytical instrumentation
market, primarily, due to strong support from government research
The Life Sciences Laboratory Instrumentation
market comprises primarily of segments such as Centrifugation, Flow
Cytometry, PCR and Spectrophotometer, Electrophoresis equipments. While
these segments grab a major share of the total market pie, other
minuscule segments include gene and protein sequencing along with
imaging. The total Lab Instrumentation market in 2009-2010 stood at Rs
920 crore. Major players in the Lab Instrumentation market include
Thermo Fisher Scientific, ABI, Beckman Coulter, Bio-Rad, Eppendorf,
(Abbott Molecular & Dako), Roche, ABI, Perkin Elmer, GE, and
The total market size for centrifuges in 2009-2010 stood between Rs
100-120 crore and roughly 5,000 units in terms of volume. This segment
again can be broken down to various sub-segments that include High
Speed Centrifuges, Ultra Centrifuges, Table Top Centrifuges and
Industrial Centrifuges. Market size for Ultra Centrifuges stood between
Rs 30-32 crore ($5-7 million) while market size for high speed
centrifuges stood at Rs 9.2 crore ($2 million) in 2009-2010. And if we
include uptakes in blood banks then the figure for high speed
centrifuges would touch the same mark as Ultra Centrifuges of Rs 30-32
crore ($ 5-7 million).
While Ultra and High Speed Centrifuges cater to a very niche market
segment (mainly the vaccine manufacturers), the market for Table Top
Centrifuges is huge in India and revenue sales stood at Rs 36.8 crore
($8-10 million). Both Ultra and High Speed Centrifuges is mainly used
for research and vaccine manufacturing processes. Major players in
India in the Ultra Centrifuge space include Beckman Coulter with an 80
percent market share followed by Beckman. Major players in the High
Speed Centrifugation segment again include Beckman Coulter and Thermo
Fisher Scientific with Beckman Coulter having a market share of 55
percent followed by Thermo Fisher Scientific. High speed rotators are
mainly available at 1.5 litres, 6 litres, 9 litres and 12 litres in
India. While Beckman Coulter markets centrifuges up to 9 litres, Thermo
Fisher Scientific has brought out centrifuges of up to 12 litres which
is mainly in use for industrial purposes. Thermo Fisher Scientific also
looks at, blood centrifuges having a stupendous market share of 70-80
Table Top Centrifuges can be further sub-divided into mini micro
centrifuges and micro centrifuges. Major players in the segment include
Eppendorf having 30 percent market share followed by Sigma Aldrich,
Thermo Fisher Scientific and Hitachi (operating in India through
various distribution channels). These segments apart, there have been
up upcoming segments like industrial centrifuges and continuous flow
centrifuges. Prominent companies in industrial centrifuges include Alfa
Laval and this again is mainly aimed at the emerging vaccine segment.
However, this again is a niche segment due to only a handful of
prominent vaccine players operating in the country. Eighty percent of
the centrifugation instruments are imported while only 20 percent are
local products manufactured by Remi and Plastocraft.
Flow Cytometry in India clocked a market size of Rs 115 crore ($25
million). This segment can further be sub-divided into research flow
cytometry, diagnostics flow cytometry and imaging flow cytometry. Major
players in this segment include Becton Dickinson and Beckman Coulter.
Being a high-end technology, Flow Cytometry is still in its nascent
phase in India with just a handful of expertise available to operate on
this technology. While in research, Flow Cytometry is used for checking
toxicity, proteomics and genomics, in diagnostics, the technology is
used right from low-end HIV testing to high-end cancer research.
The other popular segment, PCR market in 2009-2010 witnessed an
approximate growth rate of 7-8 per cent, clocking total revenue sales
of Rs 55 crore. During the year, around 900-950 PCR units were sold.
Including Real Time PCR, the volume reaches 1,100 units. Major players
in the real time PCR market include ABI (with a market share of >40
per cent), Eppendorf (market share of 25-30 per cent) followed by
BioRad and Roche at 15-20 percent each.
The classical PCR market represented by Eppendorf has 30 percent market
share followed by Bio-Rad with 30 percent market share. ABI with 10-15
percent share witnessed a single digit growth of 6-7 percent in 2009.
The real time PCR market has, however, grown faster with a growth rate
of upto15 percent due to the H1N1 outbreak. Around 150 RT PCR
instruments were sold in 2009. Seed testing labs are the top most
clients for PCR instruments especially those testing on rice, maize and
Bt brinjal. Most of these laboratories, located in the Hyderabad,
Aurangabad and Jalna belt opt for high-throughput PCRs. However, demand
for most PCRs from the plant sciences industry are seasonal in nature,
as it primarily depends on the season of the plant/crop. While a normal
laboratory would opt for one PCR, a normal seed testing laboratory
would opt for four PCRs which can test 384 samples at one time. In
addition to this, there are a number of institutions working on seed
genome projects like rice and maize and companies selling PCRs are
bullish that this could be a growth area in the coming years. In
addition, the demand for PCRs from these institutions will not dry up
for a long time. Moreover, the growth of the reagents industry at 20-25
per cent has also accelerated the growth of the PCR segment. Though
there is much emphasis on drug discovery in India, the demand for PCRs
is less compared to the plant sciences industry, primarily, because in
drug discovery, a PCR is needed only for gene sequencing. In addition
to this, PCRs used in molecular diagnostic labs has not yet picked up
as there are few labs in the country who opt for offering molecular
solutions. On the whole, major part of the business comes from
government laboratories not just because they have the funds but also
because PCRs have become an absolute necessity.
Other minor segments like Gene sequencing has a market size of Rs 25-30
crore in India. Major players include Roche Applied Biosystems and
Illumina. There are around 20 placements, on an average, every year.
Globally, 70 percent of market is held by Illumina while in India it is
30 percent. Many companies are now focusing on single molecule
sequencing technology which is an upcoming technology. Again major part
of this business comes from government research labs.
Liquid handling systems is yet another segment which contributed
roughly around Rs 100 crore. It mainly comprises products such as
automated liquid handlers, dispensers, pipettes, etc. This business was
not impacted much during 2009. Eppendorf a dominant player in this
segment sold over 20,000 pipettes last year. Other important companies
are Gilson, Biohit, Thermo, Tecan, Beckman Coulter and Qiagen.
- The total lab instrumentation market in 2009 stood at Rs 920
- The total market size for centrifuges stood between Rs 100-120
crore and roughly 5,000 units in terms of volume.
- Flow Cytometry in India clocked a revenue of Rs 115 crore.
- PCR market witnessed a growth of 7-8 percent, clocking total
revenue of Rs 55 crore.
- Around 900-950 PCR units were sold. Including Real Time PCR, the
volume was 1,100 units.
- While classical PCR market witnessed a single digit growth of 6-7
percent, real time PCR market grew faster at 15 percent due to the H1N1
- Liquid handling systems contributed around Rs 100 crore.